Trials / Completed
CompletedNCT00794248
Preference for Clarinex Tablets vs. Allegra Tablets in Patients With Seasonal Allergies (Study P03179)
Preference Evaluation of Clarinex Tablets vs. Allegra Tablets in Subjects With Symptomatic Seasonal Allergic Rhinitis
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 122 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This was a crossover study designed to see if patients with seasonal allergy symptoms preferred Clarinex® or Allegra®. Patients were randomized to take 7 days of Clarinex or Allegra treatment, followed by a 5 to 28-day washout period (days when no drug is given), followed by 7 days of the opposite treatment. At the end of each 7-day treatment, patients were asked questions to determine which drug, Clarinex or Allegra, the patient prefers more.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | desloratadine 5 mg | Clarinex 5 mg daily x 7 days |
| DRUG | fexofenadine | Allegra 180 mg daily x 7 days |
Timeline
- Start date
- 2002-11-01
- Primary completion
- 2003-05-01
- Completion
- 2003-05-01
- First posted
- 2008-11-20
- Last updated
- 2022-02-17
Source: ClinicalTrials.gov record NCT00794248. Inclusion in this directory is not an endorsement.